Case: 12-1523 Document: 43 Page: 1 Filed: 10/15/2012

NOTE: This order is nonprecedential.

Wntteb ~tate~ «ourt of ~peaI~ for tbe jfeberaI «treutt

THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, Plaintiff, AND

NEW YORK UNIVERSITY, Plaintiff-Cross Appellant, AND

GALDERMA LABORATORIES INC. AND GALDERMA LABORATORIES, L.P., Plaintiffs-Cross Appellants, v. MYLAN PHARMACEUTICALS INC., Defendant-Appellant,

MYLAN PHARMACEUTICALS INC., Plaintiff-Appellant, v. GALDERMA LABORATORIES INC. AND GALDERMA LABORATORIES, L.P., Defendants-Cross Appellants, AND

SUPERNUS PHARMACEUTICALS, INC., Defendant-Appellee. Case: 12-1523 Document: 43 Page: 2 Filed: 10/15/2012

RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS 2

2012-1523, -1524, -1555, -1556, -1557

Appeals from the United States District Court for the District of Delaware in case nos. 09-CV-0184 and 10-CV- 0892, Judge Leonard P. Stark.

THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, Plaintiff, AND

SUPERNUS PHARMACEUTICALS, INC., Plaintiff-Appellee,

AND

NEW YORK UNIVERSITY, Plaintiff-Cross Appellant,

AND

GALDERMA LABORATORIES INC. AND GALDERMA LABORATORIES, L.P., Plaintiffs-Cross Appellants v.

IMPAX LABORATORIES, INC., Defendant-Appellant.

2012-1545, -1546, -1590, -1591, -1592 Case: 12-1523 Document: 43 Page: 3 Filed: 10/15/2012

3 RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS

Appeals from the United States District Court for the District of Delaware in case nos. 09-CV-0703 and 11-CV- 0477, Judge Leonard P. Stark.

GALDERMA LABORATORIES INC. AND GALDERMA LABORATORIES, L.P., Plaintiffs-Cross Appellants, AND

SUPERNUS PHARMACEUTICALS, INC., Plaintiff-Appellee,

v.

LUPIN LIMITED AND LUPIN PHARMACEUTICALS, INC., Defendants-Appellants.

2012-1566, -1596

Appeals from the United States District Court for the District of Delaware in case no. 10-CV-1112, Judge Leo- nard P. Stark.

THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, Plaintiff, AND

NEW YORK UNIVERSITY, Plaintiff-Appellant, AND Case: 12-1523 Document: 43 Page: 4 Filed: 10/15/2012

RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS 4

GALDERMA LABORATORIES INC. AND GALDERMA LABORATORIES, L.P., Plaintiffs-Appellants v.

LUPIN LIMITED AND LUPIN PHARMACEUTICALS, INC., Defendants-Cross Appellants.

2012-1597, -1598, -1599

Appeals from the United States District Court for the District of Delaware in case no. 09-CV-0483, Judge Leo- nard P. Stark.

ON MOTION

ORDER Upon consideration of Galderma Laboratories Inc., et al.'s unopposed motions to consolidate the above cap- tioned appeals and set the briefing schedule,

IT Is ORDERED THAT:

(1) The motions are granted. Mylan Pharmaceuticals, Inc., Impax Laboratories, Inc., Lupin Limited, and Lupin Pharmaceuticals, Inc.'s principal briefs are due October 1, 2012. Galderma Laboratories Inc., Galderma Laborato- ries, L.P., Supernus Pharmaceuticals, Inc., and New York University's principal and response briefs are due No- vember 13, 2012. Mylan, Impax, and Lupin's re- Case: 12-1523 Document: 43 Page: 5 Filed: 10/15/2012

5 RESEARCH FOUNDATION V. MYLAN PHARMACEUTICALS

sponse/reply briefs are due December 26,2012. Galderma and New York University's reply briefs are due January 11,2013.

(2) The revised official caption is reflected above.

FOR THE COURT

/s/ Jan Horbaly Jan Horbaly Clerk s26